aminophylline has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dick, R; Doukky, R; Morales Demori, R; Rangel, MO; Voll, ST; Wassouf, M | 1 |
| Alqaid, A; Dick, R; Doukky, R; Margeta, B; Rangel, MO; Wassouf, M | 1 |
2 trial(s) available for aminophylline and Chronic Kidney Diseases
| Article | Year |
|---|---|
Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Cardiotonic Agents; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Gastrointestinal Tract; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Renal Insufficiency, Chronic | 2015 |
Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial.
Topics: Adenosine A2 Receptor Agonists; Adult; Aged; Aminophylline; Chi-Square Distribution; Chicago; Diarrhea; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Odds Ratio; Predictive Value of Tests; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |